AKT1 and osteosarcoma: NCTD can inhibit the proliferation of osteosarcoma cells by blocking the Akt/mTOR signal transduction pathway and inducing G2/M cell cycle arrest in 143B and SJSA osteosarcoma cells in a dose- and time-dependent manner.